These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 14109898)

  • 21. Evaluation of rapidly disintegrating tablets containing glycine and carboxymethylcellulose.
    Fukami J; Yonemochi E; Yoshihashi Y; Terada K
    Int J Pharm; 2006 Mar; 310(1-2):101-9. PubMed ID: 16434157
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Incompatibility of croscarmellose sodium with alkaline excipients in a tablet formulation.
    Bindra DS; Stein D; Pandey P; Barbour N
    Pharm Dev Technol; 2014 May; 19(3):285-9. PubMed ID: 23528069
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Influence of formation of an hydrophilic and continuous network of starch on tablet properties. III. Investigation on mathematical determination of the best starch concentration which garantee the best level of bioavailability from tablets (author's transl)].
    Ringard J; Guyot-Hermann AM
    J Pharm Belg; 1979; 34(4):204-11. PubMed ID: 501514
    [No Abstract]   [Full Text] [Related]  

  • 24. Evaluation of Ceolus™ microcrystalline cellulose grades for the direct compression of enteric-coated pellets.
    Kucera SU; DiNunzio JC; Kaneko N; McGinity JW
    Drug Dev Ind Pharm; 2012 Mar; 38(3):341-50. PubMed ID: 21870908
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Loss of fluoride during tablet production.
    Sabo M; Caputo JF; Parott EL
    J Pharm Sci; 1976 Jun; 65(6):932-. PubMed ID: 932987
    [No Abstract]   [Full Text] [Related]  

  • 26. [Sodium carboxymethylcellulose as a binding agent in the preparation of tablets].
    NOSOVITSKIA SA; BORZUNOV EE; SAFIULIN RM
    Farm Zh; 1962; 17(4)():6-8. PubMed ID: 13939019
    [No Abstract]   [Full Text] [Related]  

  • 27. [Investigation of Oral Preparation That Is Expected to Improve Medication Administration: Preparation and Evaluation of Oral Gelling Tablet Using Sodium Alginate].
    Ito I; Ito A; Unezaki S
    Yakugaku Zasshi; 2017; 137(8):969-977. PubMed ID: 28768950
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Correlating bilayer tablet delamination tendencies to micro-environmental thermodynamic conditions during pan coating.
    Zacour BM; Pandey P; Subramanian G; Gao JZ; Nikfar F
    Drug Dev Ind Pharm; 2014 Jun; 40(6):829-37. PubMed ID: 23638984
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The consolidation and compressibility properties of some novel directly compressible filler-binders.
    Gönül N; Oğan-Hasçiçek C; Baykara T
    Acta Pol Pharm; 2000; 57(4):311-7. PubMed ID: 11126621
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Design development and evaluation of triphala tablets.
    Mouriya N; Valvi A; Athawale R; Bhatt N
    J Complement Integr Med; 2017 Mar; 14(2):. PubMed ID: 28284034
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In-line quantification of micronized drug and excipients in tablets by near infrared (NIR) spectroscopy: Real time monitoring of tabletting process.
    Karande AD; Heng PW; Liew CV
    Int J Pharm; 2010 Aug; 396(1-2):63-74. PubMed ID: 20558264
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [A Method for Decreasing the Amount of the Drug Remaining on the Surfaces of the Mortar and Pestle after Grinding Small Amount of Tablets].
    Kawakami M; Kitada R; Kurita T; Tokumura T
    Yakugaku Zasshi; 2017; 137(8):1017-1025. PubMed ID: 28768941
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of cellulose II powders as a potential multifunctional excipient in tablet formulations.
    de la Luz Reus Medina M; Kumar V
    Int J Pharm; 2006 Sep; 322(1-2):31-5. PubMed ID: 16828996
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tablet preformulations of indomethacin-loaded mesoporous silicon microparticles.
    Tahvanainen M; Rotko T; Mäkilä E; Santos HA; Neves D; Laaksonen T; Kallonen A; Hämäläinen K; Peura M; Serimaa R; Salonen J; Hirvonen J; Peltonen L
    Int J Pharm; 2012 Jan; 422(1-2):125-31. PubMed ID: 22063301
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Galenic forms and availability of theophylline. II. Influence of the content of the active principle and parameters of tablet manufacture].
    Duru C; Jacob M; Joachim J; Gaudy D; Parent P; Puech A
    Pharm Acta Helv; 1985; 60(1):17-21. PubMed ID: 3975234
    [No Abstract]   [Full Text] [Related]  

  • 36. Retard implantation tablets on a matrix base with Eudragit as a structural substance.
    Korsatko W
    Pharmazie; 1982 Apr; 37(4):272-3. PubMed ID: 7100251
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Co-Processed Excipients for Dispersible Tablets-Part 2: Patient Acceptability.
    Dziemidowicz K; Lopez FL; Bowles BJ; Edwards AJ; Ernest TB; Orlu M; Tuleu C
    AAPS PharmSciTech; 2018 Aug; 19(6):2646-2657. PubMed ID: 29943280
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative evaluation of two direct compression lactose grades for pyridoxine hydrochloride tablets.
    Aly SA; Udeala OK
    Pharmazie; 1988 Mar; 43(3):188-90. PubMed ID: 3380861
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Study of the interaction between policosanol and excipients.
    Cabrera L; Uribarri E; Laguna A; Sierra R; Mederos D; González M; González V
    Boll Chim Farm; 2002; 141(2):138-42. PubMed ID: 12135162
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Continuous direct tablet compression: effects of impeller rotation rate, total feed rate and drug content on the tablet properties and drug release.
    Järvinen MA; Paaso J; Paavola M; Leiviskä K; Juuti M; Muzzio F; Järvinen K
    Drug Dev Ind Pharm; 2013 Nov; 39(11):1802-8. PubMed ID: 23163644
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.